www.fdanews.com/articles/97443-andromeda-phase-iii-trial-costs-weigh-on-clal-biotech-results
Andromeda Phase III Trial Costs Weigh on Clal Biotech Results
August 21, 2007
IDB Holding subsidiary Clal Biotechnology Industries published its financial report for the second quarter of 2007.
Globes